Abortion pill rulings spark controversy and calls for action.

Two federal judges issued conflicting rulings on the approval and access to the abortion drug mifepristone, setting up a legal clash that could be decided by the Supreme Court. The conservative groups that sued the FDA in Texas cherry-picked a judge known for his anti-abortion views, while Democratic attorneys general sued the Biden administration to demand fewer FDA restrictions on access to the abortion pill in their states. The conflicting cases would present justices with their biggest test on abortion access since their landmark decision in June to overturn the guarantee of abortion rights provided by Roe v. Wade.